| Stephen Mccarren, MD | |
|
2600 Sixth St Sw, Ohio Hospital Based Physicians Corp, Canton, OH 44710 | |
| (330) 363-7462 | |
| (330) 363-7679 |
| Full Name | Stephen Mccarren |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Location | 2600 Sixth St Sw, Canton, Ohio |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265493019 | NPI | - | NPPES |
| 0165002 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 35064277 (Ohio) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Stephen Mccarren, MD 2600 Sixth St Sw, Ohio Hospital Based Physicians Corp, Canton, OH 44710 Ph: (330) 363-7462 | Stephen Mccarren, MD 2600 Sixth St Sw, Ohio Hospital Based Physicians Corp, Canton, OH 44710 Ph: (330) 363-7462 |
News Archive
Scientists at UC San Francisco, UC Berkeley and UCLA have received U.S. Food and Drug Administration approval to jointly launch an early phase, first-in-human clinical trial of a CRISPR gene correction therapy in patients with sickle cell disease using the patient's own blood-forming stem cells.
In two closely related studies, two teams of Scripps Research Institute scientists have discovered the underlying mechanisms that activate a type of immune cell in the skin and other organs. The findings may lead to the development of new therapies to treat inflammation, wounds, asthma, and malignant tumors.
Researchers from the UK and Germany recently reported a comprehensive characterization of the SARS-CoV-2 response of human nasal epithelial cells, revealing a response dominated by IFN-I/IIIs. Also, recombinant IFN-I/III treatment was found to efficiently block the replication of SARS-CoV-2, which suggests that mucosal delivery of IFNs may be a good strategy for prophylaxis post-exposure.
Actavis plc, a leading global specialty pharmaceutical company, and Medicines360, a nonprofit women's health pharmaceutical company, today announced the approval of LILETTA (levonorgestrel-releasing intrauterine system) by the U.S. Food and Drug Administration for use by women to prevent pregnancy for up to three years.
A randomized clinical trial has compared key-hole (laparoscopic) surgery and open surgery in pancreatic cancer patients undergoing pancreaticoduodenectomy, or the Whipple procedure.
› Verified 4 days ago
Anthony Clark, CRNA Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2600 Sixth Street Sw, Ohio Hospital Based Physician Corp, Canton, OH 44710 Phone: 330-363-7462 Fax: 330-363-7679 | |
Dr. Meghan Elizabeth Nein, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 4760 Belpar St Nw, Canton, OH 44718 Phone: 330-492-9200 | |
Brendan Joseph Mccafferty, DO Anesthesiology Medicare: Medicare Enrolled Practice Location: 1320 Mercy Dr Nw, Canton, OH 44708 Phone: 330-489-1000 Fax: 330-498-4229 | |
Dr. Michael John O'brien, D.O. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 4665 Douglas Cir Nw, Canton, OH 44718 Phone: 330-499-5700 | |
Wen Shin Liu, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 4665 Douglas Cir Nw, Suite 101, Canton, OH 44718 Phone: 330-499-5700 Fax: 330-498-4229 | |
Jeffrey Zagst, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2600 Sixth St Sw, Ohio Hospital Based Physicians Corp, Canton, OH 44710 Phone: 330-363-7462 Fax: 330-363-7679 | |
Mounir Mikhail, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 2600 Sixth St Sw, Canton, OH 44710 Phone: 330-363-7462 Fax: 330-363-7679 |